Yu Ren Wang
Keine laufenden Positionen mehr
Profil
Yu Ren Wang worked as Senior Director-Asia & Mid Atlantic at Reaction Biology Corp.
from 2013 to 2018.
He then worked as Vice President-Research & Development at Jemincare Therapeutics Corp.
in 2018-2019.
Currently, he is working as Head-Portfolio Management at Adagene, Inc. from 2019 to 2023.
Dr. Wang holds a doctorate degree from the University of Pennsylvania, a graduate degree from the Chinese Academy of Agricultural Sciences, and an undergraduate degree from Shandong Agricultural University.
Ehemalige bekannte Positionen von Yu Ren Wang
| Unternehmen | Position | Ende |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01.01.2023 |
Jemincare Therapeutics Corp.
 Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Reaction Biology Corp.
 Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01.12.2018 |
Ausbildung von Yu Ren Wang
| University of Pennsylvania | Doctorate Degree |
| Chinese Academy of Agricultural Sciences | Graduate Degree |
| Shandong Agricultural University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Reaction Biology Corp.
Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Commercial Services |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Health Technology |
